Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Blackstar Special Opportunities Fund celebrates one-year anniversary with double-digit returns

Monday, October 07, 2013

amb
Benedicte Gravrand, Opalesque Geneva, for New Managers:

A South African multi strategy hedge fund that combines high conviction special opportunity positions and other diversified investments, ends its first 12-month period on a high note.

The Blackstar Special Opportunities Fund was launched in October 2012. It returned 3.37% that year and is currently up 11.10% YTD (to end-August). And according to the portfolio managers, the fund gained an estimated 4% in September, giving it a net return of 20% for the first 12 months.

The Special Opportunities Fund is managed by Blackstar Fund Managers (Pty) Ltd., a subsidiary of Blackstar Group, a listed investment holding company. It invests in multi asset classes across multi-currencies, that takes on long and short positions with some leverage across diverse exposures with core long term theme holdings. The fund blends fundamental and technical analysis and uses quantitative screening especially for liquidity. It usually holds up to 25% exposure to foreign currency stocks and bonds, including a 7.5% holding in the Blackstar’s Global Opportunities Fund, a USD multi-strategy fund that invests exclusively outside of South Africa. Fees are 1.25% for management and 20% for performance.

The portfolio managers are Stephen Pratt, who managed his own hedge fund shop called Radcliffe Capital (2003-2012); Andrew Bonamour, ex-Brait S.A., the founder of Blacksta......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for